Welcome to our dedicated page for Icl Group Ltd. SEC filings (Ticker: ICL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ICL Group Ltd. (ICL) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer listed on both the NYSE and TASE. ICL files an annual report on Form 20-F, which includes audited financial statements prepared under IFRS, segment information for Industrial Products, Potash, Phosphate Solutions and Growing Solutions, risk factors, and Task Force on Climate-related Financial Disclosures (TCFD) describing how the company addresses climate-related risks and its carbon footprint.
In addition to the 20-F, ICL regularly submits Form 6-K current reports. These filings cover a wide range of topics, such as quarterly financial results, investor presentations, guidance on specialties-driven EBITDA and potash sales volumes, dividend declarations, potash supply agreements with customers in China, and strategic decisions like discontinuing LFP cathode active material projects while continuing to supply raw materials to the battery materials market.
ICL’s 6-K filings also document legal, regulatory and concession-related matters, including a memorandum of understandings with the Government of Israel on the valuation and future transfer of Dead Sea Concession assets, publication of a draft bill for the future concession, and a Supreme Court ruling on water fees for water extraction in the concession area. These documents provide detailed context on how concession terms, state revenues and environmental obligations may affect the company.
On this page, Stock Titan surfaces ICL’s latest SEC submissions as they are made available on EDGAR and applies AI-powered summaries to help explain the key points in each filing. Investors can use these tools to quickly understand highlights from 20-F annual reports, 6-K quarterly updates, dividend and tax announcements, and other material information without reading every page of the original documents.
ICL Group Ltd. executive Uri Perelman filed an initial ownership report showing existing stock option holdings in the company. He holds options over 1,139,990 Ordinary Shares with a $6.03 exercise price expiring on April 4, 2029, and options over 739,400 Ordinary Shares with a $6.93 exercise price expiring on April 1, 2030. The first grant vests in three equal annual installments from the April 4, 2024 grant date, while the second vests in three installments of 50%, 35% and 15% from the April 1, 2025 grant date. The options are held by a trustee in Perelman’s name, and the filing does not report any new purchases or sales, only these derivative holdings.
ICL Group Ltd. director Yoav Doppelt has reported existing holdings of stock options over the company’s ordinary shares. One grant covers 1,055,100 underlying ordinary shares at an exercise price of $11.05 per share, expiring on March 30, 2027, and is fully vested and exercisable.
A second grant covers 1,973,684 underlying ordinary shares at an exercise price of $6.73 per share, expiring on March 6, 2030. These options vest in three equal annual installments from the March 6, 2025 grant date and are held by a trustee in Doppelt’s name.
ICL Group Ltd. executive Yaniv Kabalek, President, Industrial Products, reported his initial beneficial ownership of stock options on Ordinary Shares. He holds options over 348,928 underlying shares at an exercise price of $8.33 per share, expiring on February 14, 2028. He also holds options over 627,793 underlying shares at an exercise price of $5.87 per share, expiring on April 4, 2029. Some options are fully vested and exercisable, while others vest in three equal annual installments from the April 4, 2024 grant date, and are held by a trustee in his name.
ICL Group Ltd. officer Ilani Nir filed an initial ownership report showing stock options over the company’s ordinary shares. The options give a right to buy 560,538 ordinary shares at an exercise price of $7.33 per share, expiring on July 6, 2030.
The options were granted on July 6, 2025 and vest in three equal annual installments from that grant date. They are held by a Trustee in the name of the reporting person, and reflect a direct derivative position rather than a recent market purchase or sale.
ICL Group Ltd. executive Mishor Miriam, EVP Global IT, reported existing derivative holdings in a Form 3. The filing shows stock options giving rights to acquire 464,902 Ordinary Shares at an exercise price of $9.39 per share, expiring on February 8, 2027; these options are fully vested and exercisable and are held by a Trustee in the reporting person's name.
A second option position covers 620,177 Ordinary Shares at an exercise price of $5.87 per share, expiring on April 4, 2029, vesting in three equal annual installments from the April 4, 2024 grant date. The Form 3 records these as direct beneficial holdings and does not reflect new purchases or sales, but rather the baseline option positions as of the reporting date.
ICL Group Ltd. executive Maya Grinfeld, SVP of Marketing & Communications, reported holding stock options over 189,846 Ordinary Shares. The options carry an exercise price of $7.33 per share, vest in three equal annual installments from the July 6, 2025 grant date, and expire on July 6, 2030. The options are held by a trustee in her name, reflecting a compensation-based right to buy, rather than a recent market trade.
ICL Group Ltd. Deputy Chief Executive Officer Geva Harel Lilach reported existing holdings of stock options to buy Ordinary Shares. The Form 3 lists three option grants with exercise prices in U.S. dollars, converted from New Israeli Shekels using Bank of Israel exchange rates.
One option grant covers 649,180 underlying shares at an exercise price of $9.39 per share, is fully vested and exercisable, and expires on February 8, 2027. Additional grants cover 984,095 underlying shares at $5.87 per share expiring April 4, 2029, and 416,667 underlying shares at $5.91 per share expiring December 7, 2030, each vesting in three equal annual installments from their respective grant dates. The options are held by a Trustee in the name of the reporting person.
ICL Group Ltd. executive Fahima Ilana, EVP and Chief People Officer, filed an initial statement of beneficial ownership showing significant stock option holdings in ICL Group.
She holds stock options over 649,180 ordinary shares with a $9.39 exercise price expiring on February 8, 2027, and options over 984,095 ordinary shares with a $5.87 exercise price expiring on April 4, 2029. According to the notes, one grant of stock options is fully vested and exercisable, while another grant vests in three equal annual installments from the April 4, 2024 grant date, with the options held by a trustee in her name.
ICL Group Ltd. President & CEO Elad Aharonson reported existing holdings of stock options to buy ICL ordinary shares. These options cover 306,748 underlying shares at an exercise price of $6.39 per share expiring on June 30, 2026, 737,705 underlying shares at $9.39 expiring on February 8, 2027, 1,118,290 underlying shares at $5.87 expiring on April 4, 2029, and 2,308,963 underlying shares at $6.78 expiring on March 13, 2030. Footnotes state that some options are fully vested and exercisable, while others vest in three annual installments from April 4, 2024 and March 13, 2025, including specified vesting percentages.
ICL Group Ltd. Chief Financial Officer Lahav Aviram reported his initial holdings of stock options linked to the company’s ordinary shares. He holds stock options over 784,918 underlying ordinary shares at an exercise price of $9.39 per share, expiring on February 8, 2027. He also holds stock options over 1,189,861 underlying ordinary shares at an exercise price of $5.87 per share, expiring on April 4, 2029. According to the notes, one option grant is fully vested and exercisable, while the other vests in three equal annual installments from the April 4, 2024 grant date, and the options are held by a trustee in his name.